Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

NCT07214688 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

209

Enrollment

OTHER

Sponsor class

Conditions

Allogeneic Stem Cell Transplant Recipient

Interventions

DRUG: Fludarabine
RADIATION: Intermediate-dose Total Body Irradiation (TBI)
DRUG: Post-transplant Cyclophosphamide (PTCy)
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil (MMF)

Sponsor

Hackensack Meridian Health